Skip to main content

Labor Induction

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pediatrix Therapeutics
Pediatrix TherapeuticsChina - Shanghai
1 program
CERVIDILN/A1 trial
Active Trials
NCT01402050Completed376Est. Feb 2015
Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
Misoprostol vaginal insert 25 mcgPHASE_21 trial
Active Trials
NCT00346840Completed124Est. Mar 2004

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ferring PharmaceuticalsMisoprostol vaginal insert 25 mcg
Pediatrix TherapeuticsCERVIDIL

Clinical Trials (2)

Total enrollment: 500 patients across 2 trials

NCT00346840Ferring PharmaceuticalsMisoprostol vaginal insert 25 mcg

Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

Start: Jun 2003Est. completion: Mar 2004124 patients
Phase 2Completed

Foley Catheter Versus Cervidil for Induction of Labor at Term

Start: Jun 2010Est. completion: Feb 2015376 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.